Temporary right heart catheterization in a stable state improves prognosis by optimizing guideline-directed medical therapy in patients with acute heart failure

29 August 2025 (12:15 - 13:00)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Ryuichi Matsukawa

Aso Iizuka Hospital, Iizuka (Japan)

6 More presentations in this session

Presentation thumbnail

The experience of more than three hundred levosimendan administrations: what we have learned

Doctor F. Gerardo (Amadora, PT)

Abstract Slides Video

Presentation thumbnail

Albuminuria and acute heart failure. Prognostic implications and short-term mortality.

Doctor M. Galvan Ruiz (Las Palmas de Gran Canaria, ES)

Abstract Slides Video

Presentation thumbnail

Two-year outcomes in acute heart failure patients stratified by left ventricular ejection fraction

Doctor A. Feuerstein (Berlin, DE)

Abstract Slides Video

Presentation thumbnail

The hemodynamic and cardiometabolic effects of butyrate infusion in ischemic cardiogenic shock

Mr L. Christensen (Aarhus N, DK)

Abstract Slides Video

Presentation thumbnail

Assessment of biomarkers for iron deficiency following acute decompensated heart failure and its outcomes: a retrospective real-world clinical cohort study

Doctor J. Johansson (Gothenburg, SE)

Abstract Slides Video

Access the full session

Session thumbnail

Acute heart failure: new insights and treatments

The Event

Event poster

ESC Congress 2025

29 August 2025 12:15 CET

You may be interested in

Congress Presentation

Timing of the use of guideline-directed medical therapy

Congress Presentation

How to manage guideline-directed medical therapy around decongestion

Congress Presentation

Adjusting guideline-directed medical therapy during acute heart failure hospitalisation: the why, the what, the when, and the how

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources